Cargando…

PM365. Effects of sulforaphane in the maternal immune activation model of schizophrenia

Detalles Bibliográficos
Autores principales:	Matsuura, Akiko, Fujita, Yuko, Iyo, Masaomi, Hashimoto, Kenji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2016
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5616301/ http://dx.doi.org/10.1093/ijnp/pyw041.365

Ejemplares similares

An Open Study of Sulforaphane-rich Broccoli Sprout Extract in Patients with Schizophrenia
por: Shiina, Akihiro, et al.
Publicado: (2015)

Dietary glucoraphanin prevents the onset of psychosis in the adult offspring after maternal immune activation
por: Matsuura, Akiko, et al.
Publicado: (2018)

PM367. Effect of cannabidiol on cognition in a maternal immune activation (poly IC) model of schizophrenia
por: Osborne, Ashleigh L., et al.
Publicado: (2016)

Neonatal Disruption of Serine Racemase Causes Schizophrenia-Like Behavioral Abnormalities in Adulthood: Clinical Rescue by D-Serine
por: Hagiwara, Hiroko, et al.
Publicado: (2013)

Effects of the Antioxidant Sulforaphane on Hyperlocomotion and Prepulse Inhibition Deficits in Mice after Phencyclidine Administration
por: Shirai, Yumi, et al.
Publicado: (2012)

Treatment of refractory catatonic schizophrenia with low dose aripiprazole
por: Sasaki, Tsuyoshi, et al.
Publicado: (2012)

Genetic association between G protein-coupled receptor kinase 6/β-arrestin 2 and dopamine supersensitivity psychosis in schizophrenia
por: Oda, Yasunori, et al.
Publicado: (2015)

Supplementation with D-serine prevents the onset of cognitive deficits in adult offspring after maternal immune activation
por: Fujita, Yuko, et al.
Publicado: (2016)

PM448. Investigation of maternal effects, maternal-fetal interactions and parent-of-origin effects (imprinting), using mothers and their offspring with schizophrenia
por: Lee, Byung Dae, et al.
Publicado: (2016)

PM461. Inflammation in schizophrenia: Imaging genetics
por: Hwang, Wu Jeong, et al.
Publicado: (2016)

PM394. The outcome of paliperidone palmitate in schizophrenia
por: Ju, Po-Chung
Publicado: (2016)

PM363. The effect of Ketamine: Gunn rat as a Schizophrenia animal model
por: Hayashida, Maiko, et al.
Publicado: (2016)

PM533. The Five-Factor Model Personality Traits in Schizophrenia: Meta-Analysis
por: Shimada, Takamitsu, et al.
Publicado: (2016)

TME6/365: Teleconsultation and Telescreening for Eye Diseases
por: Zahlmann, G, et al.
Publicado: (1999)

PS64. Psychiatrists' thinking about how to prescribe psychotropic drugs in out-patients with major depressive disorder and bipolar disorder in general clinical practice compared to the evidence-based guidelines.
por: Koseki, Maiko, et al.
Publicado: (2016)

PM464. Effect of Anhedonia on Shopping Behavior in Schizophrenia
por: Kim, Min-Kyeong, et al.
Publicado: (2016)

Alterations of Dopamine D2 Receptors and Related Receptor-Interacting Proteins in Schizophrenia: The Pivotal Position of Dopamine Supersensitivity Psychosis in Treatment-Resistant Schizophrenia
por: Oda, Yasunori, et al.
Publicado: (2015)

PM388. Brain function measures of therapeutic effects of pharmacotherapy in schizophrenia: An fMRI study
por: Hasegawa, Sayaka, et al.
Publicado: (2016)

Repeated intermittent administration of (R)-ketamine during juvenile and adolescent stages prevents schizophrenia-relevant phenotypes in adult offspring after maternal immune activation: a role of TrkB signaling
por: Tan, Yunfei, et al.
Publicado: (2022)

PM370. Mismatch negativity and theta band oscillation in schizophrenia and rodent NMDAR models
por: Lee, Migyung, et al.
Publicado: (2016)

365. Hospitalizations Associated with Strongyloidiasis in the United States, 2003-2018
por: Inagaki, Kengo, et al.
Publicado: (2022)

PM358. Antidepressant Prescription pattern and Clinical Correlates for Schizophrenia
por: Kim, Jungwon, et al.
Publicado: (2016)

PM391. THE USE OF AMISULPRIDE IN TREATMENT OF PATIENTS WITH RESIDUAL SCHIZOPHRENIA
por: Janjic, Vladimir, et al.
Publicado: (2016)

PM518. Medication Adherence in schizophrenia: Focus on therapeutic relationship
por: Chang, Jhin-Goo, et al.
Publicado: (2016)

Dietary intake of glucoraphanin during pregnancy and lactation prevents the behavioral abnormalities in the offspring after maternal immune activation
por: Fujita, Yuko, et al.
Publicado: (2020)

Potentiation of Nerve Growth Factor-Induced Neurite Outgrowth by Fluvoxamine: Role of Sigma-1 Receptors, IP(3) Receptors and Cellular Signaling Pathways
por: Nishimura, Tomoko, et al.
Publicado: (2008)

PM478. Imaging the effects of d-amphetamine in the human brain for modelling dopaminergic alterations in schizophrenia
por: Willeit, Matthäus, et al.
Publicado: (2016)

PM373. Behavioral and neurochemical abnormalities in heterozygous Reelin Orleans mutant mouse model of schizophrenia
por: Yamada, Kiyofumi, et al.
Publicado: (2016)

PM541. Computational modeling of cognitive deficits from cortical circuit dysfunction associated with schizophrenia
por: Murray, John
Publicado: (2016)

PM429. Comparison of haloperidol and blonanserin on development of dopamine supersensitivity after chronic treatment
por: Hashimoto, Takashi, et al.
Publicado: (2016)

PM443. The ECT Augmenting Effects for Patients with Clozapine-Resistant Schizophrenia
por: Kim, Hye Sung, et al.
Publicado: (2016)

PM543. A Data Mining Algorithm for Personalized Medicine in Schizophrenia
por: Lee, Beom S., et al.
Publicado: (2016)

Dietary Intake of Sulforaphane-Rich Broccoli Sprout Extracts during Juvenile and Adolescence Can Prevent Phencyclidine-Induced Cognitive Deficits at Adulthood
por: Shirai, Yumi, et al.
Publicado: (2015)

PM463. Dysfunction of intrinsic and extrinsic motivation in schizophrenia: an fMRI study
por: Kim, Byung-Hoon, et al.
Publicado: (2016)

PM468. Alterations of structural connectivity in patients with schizophrenia: a systematic review
por: Oh, Hye Rim, et al.
Publicado: (2016)

PM400. Differences in assessing insight into psychosis between clinicians and patients with schizophrenia
por: Kwak, Sook Young, et al.
Publicado: (2016)

PM401. NMDA-enhancing agents improve cognitive function of patients with schizophrenia
por: Lane, Hsien-Yuan
Publicado: (2016)

PM407. Factors of Caregiver Burden and Quality of Life in Caregivers of Patients with Schizophrenia
por: Maeng, Seri
Publicado: (2016)

PM425. Relationship between suicidality and low self-esteem in patients with schizophrenia
por: Yoo, Taeyoung
Publicado: (2016)

PM521. Relationship between Negative Symptoms and Social Cognition in Patient with Schizophrenia
por: Hyun, Jiewon, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_eb78trbgfsqsm2sj412uhav563